Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
30 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/us-fda-approves-leqembi-iqklik-lecanemab-irmb-subcutaneous-injection-for-maintenance-dosing-for-the-treatment-of-early-alzheimers-disease-302542433.html
29 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/eisai-secures-highly-anticipated-fda-green-light-leqembi-iqlik-autoinjector-teeing-home
25 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/leqembi-lecanemab-launched-in-the-eu-today-302537470.html
31 Jul 2025
// BIOSPACE
https://www.biospace.com/drug-development/biogen-eisais-leqembi-slows-alzheimers-progression-through-4-years-of-treatment
31 Jul 2025
// BIOSPACE
https://www.biospace.com/business/biogens-leqembi-push-getting-easier-as-ceo-eyes-early-stage-pipeline-restock
21 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eisai-to-present-four-year-efficacy-and-safety-data-on-continuous-treatment-with-lecanemab-at-the-alzheimers-association-international-conference-2025-302509714.html
Inspections and registrations
ABOUT THIS PAGE
Eisai is a supplier offers 18 products (APIs, Excipients or Intermediates).
Find a price of Azilsartan bulk with JDMF offered by Eisai
Find a price of Donepezil bulk with JDMF offered by Eisai
Find a price of Epalrestat bulk with JDMF offered by Eisai
Find a price of Eribulin bulk with JDMF offered by Eisai
Find a price of Fosravuconazole bulk with JDMF offered by Eisai
Find a price of Pranlukast Hydrate bulk with JDMF offered by Eisai
Find a price of Rabeprazole Sodium bulk with JDMF offered by Eisai
Find a price of Ramelteon bulk with JDMF offered by Eisai
Find a price of Teprenone bulk with JDMF offered by Eisai
Find a price of Bentiromide bulk offered by Eisai
Find a price of Eperisone bulk offered by Eisai
Find a price of Menfegol bulk offered by Eisai
Find a price of Donepezil bulk offered by Eisai
Find a price of Eribulin bulk offered by Eisai
Find a price of Lenvatinib Mesylate bulk offered by Eisai
Find a price of Perampanel bulk offered by Eisai
Find a price of Rabeprazole Sodium bulk offered by Eisai
Find a price of Teprenone bulk offered by Eisai